From November 5, 2021 to December 31, 2021, the company has repurchased 248,700 shares, representing 0.65% for ¥841.01 million. With this, the company has completed the repurchase of 248,700 shares, representing 0.65% for ¥841.01 million under the buyback announced on November 5, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,955 JPY | -0.07% | -3.27% | -9.63% |
25/04 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
21/03 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.63% | 668M | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 5, 2021.